Inventor · disambiguated record
Hans-Peter Gerber
Also filed as: GERBER HANS-PETER
19 granted patents·20 pending applications·531 citations·filing 2001–2023
96Inventor score
Top patents by PatentIndex Score
39 records- 0198US7758859B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted Jul 20, 2010·76 cites·40 claims
- 0298US7691977B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted Apr 6, 2010·83 cites·13 claims
- 0396US7811785B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted Oct 12, 2010·32 cites·18 claims
- 0495US8586049B2Antibody-drug conjugatesGERBER HANS-PETER·Filed 2012·Granted Nov 19, 2013·41 cites·11 claims
- 0595US8492527B2Anti-VEGF antibodiesFUH GERMAINE·Filed 2011·Granted Jul 23, 2013·21 cites·15 claims
- 0695US8309094B2Antibody-drug conjugatesGERBER HANS-PETER·Filed 2012·Granted Nov 13, 2012·59 cites·6 claims
- 0795US8101177B2Anti-VEGF antibodiesFUH GERMAINE·Filed 2010·Granted Jan 24, 2012·22 cites·14 claims
- 0894US8512699B2Anti-VEGF antibodiesFUH GERMAINE·Filed 2010·Granted Aug 20, 2013·21 cites·15 claims
- 0994US8092797B2Anti-VEGF antibodiesFUH GERMAINE·Filed 2010·Granted Jan 10, 2012·19 cites·20 claims
- 1093US9353177B2Anti-VEGF antibodiesGENENTECH INC·Filed 2015·Granted May 31, 2016·8 cites·19 claims
- 1193US8242252B2CD19 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2011·Granted Aug 14, 2012·29 cites·19 claims
- 1292US8470329B2Combination therapy with antibody-drug conjugatesOFLAZOGLU EZOGELIN·Filed 2012·Granted Jun 25, 2013·21 cites·20 claims
- 1391US10254286B2Methods for detecting 5T4-positive circulating tumor cells and methods of diagnosis of 5T4-positive cancer in a mammalian subjectPFIZER·Filed 2013·Granted Apr 9, 2019·17 cites·16 claims
- 1489US8263083B2Combination therapy with antibody-drug conjugatesOFLAZOGLU EZOGELIN·Filed 2008·Granted Sep 11, 2012·24 cites·13 claims
- 1588US7267819B2Composition comprising and method of using angiopoietin-like protein 3 Angptl3GENENTECH INC·Filed 2002·Granted Sep 11, 2007·38 cites·17 claims
- 1685US9018357B2Anti-VEGF antibodiesGENENTECH INC·Filed 2013·Granted Apr 28, 2015·4 cites·8 claims
- 1785US8975381B2Anti-VEGF antibodiesGENENTECH INC·Filed 2013·Granted Mar 10, 2015·5 cites·12 claims
- 1885US8541376B2Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3FERRARA NAPOLEONE·Filed 2008·Granted Sep 24, 2013·11 cites·8 claims
- 1983US11833216B2Anti-EDB antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Granted Dec 5, 2023·0 cites·25 claims
- 2083US2024261423A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Application pending·0 cites
- 2183US2024181071A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Application pending·0 cites
- 2283US2024156977A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Application pending·0 cites
- 2366US2019269791A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2017·Application pending·0 cites
- 2462US2017073405A1Anti-vegf antibodiesGENENTECH INC·Filed 2016·Application pending·0 cites
- 2560US2008166724A1VEGF-Modulated Genes and Methods Employing ThemCURAGEN CORP·Filed 2007·Application pending·0 cites
- 2660US2014081005A1Antibody-drug conjugatesWYETH LLC·Filed 2013·Application pending·0 cites
- 2760US2007264193A1Diagnostics and treatments for tumorsGENENTECH INC·Filed 2007·Application pending·0 cites
- 2857US2008274993A1Methods and compositions for modulating vascular integrityGENENTECH INC·Filed 2008·Application pending·0 cites
- 2955US2008206243A1Methods for Treating Kidney DisordersGENENTECH INC·Filed 2008·Application pending·0 cites
- 3054US2017319711A1Antibody-drug conjugatesWYETH LLC·Filed 2016·Application pending·0 cites
- 3154US2007134250A1Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3GENENTECH INC·Filed 2006·Application pending·0 cites
- 3253US2004006780A1VEGF-modulated genes and methods employing themFiled 2003·Application pending·0 cites
- 3352US2006281680A1Methods and compositions for modulating vascular integrityGENENTECH INC·Filed 2006·Application pending·0 cites
- 3452US2007264259A1Methods for treating kidney disordersGENENTECH INC·Filed 2007·Application pending·0 cites
- 3551US2015175689A1Anti-vegf antibodiesGENENTECH INC·Filed 2015·Application pending·0 cites
- 3650US2003224984A1Compositions and methods for the diagnosis and treatment of disorders involving angiogenesisGENENTECH INC·Filed 2002·Application pending·0 cites
- 3748US2002132978A1VEGF-modulated genes and methods employing themFiled 2001·Application pending·0 cites
- 3845US2007250941A1VEGF Receptor Conditional Knockout Animals and Methods of UseGENENTECH INC·Filed 2007·Application pending·0 cites
- 3939US2010239568A1Diagnostics and treatments for tumorsGENENTECH INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hans-Peter Gerber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →